Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell sector : Professional, scientific, and technical services save search
Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle Platform
Published: 2023-09-11 (Crawled : 12:00) - globenewswire.com
LYEL | $2.24 -3.86% -4.02% 1.1M
|
Professional, Scientific, and T...
|
| O: 4.4%
H: 7.88%
C: 5.26%
t-cell cell therapy platform
Panbela Announces Sponsored Research Agreement to Evaluate Polyamine Metabolic Inhibitor Therapy in Combination with CAR-T Cell Therapy
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
PBLA | $0.4895 -6.31% 66K
|
Professional, Scientific, and T...
|
| O: 13.23%
H: 22.83%
C: -16.44%
metabolic cell research car-t agreement therapy
ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological Target, Tropomyosin Receptor Kinase B, Associated with Poor Prognosis and Survival Rates
Published: 2023-03-23 (Crawled : 13:00) - biospace.com/
IPA | $1.24 0.0% 150K
|
Professional, Scientific, and T...
|
| O: 0.34%
H: 2.97%
C: -0.68%
t-cell unique
Molecular Partners Presents New Preclinical Data Supporting its MP0533 DARPin T-Cell Engager for the Treatment of AML
Published: 2022-12-13 (Crawled : 01:00) - globenewswire.com
MOLN | News | $3.74 -3.54% 6.2K
|
Professional, Scientific, and T...
|
| O: 1.94%
H: 1.17%
C: 1.17%
mp0533 treatment preclinical aml t-cell molecular
Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors
Published: 2022-11-07 (Crawled : 13:20) - globenewswire.com
LYEL | $2.24 -3.86% -4.02% 1.1M
|
Professional, Scientific, and T...
|
| O: 5.02%
H: 0.0%
C: -8.47%
growing tumors
Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
LYEL | $2.24 -3.86% -4.02% 1.1M
|
Professional, Scientific, and T...
|
| O: -0.88%
H: 2.15%
C: 0.51%
preclinical immunotherapy meeting growing t-cell cancer
Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 00:00) - globenewswire.com
BMEA | $10.87 -2.6% -2.67% 1.3M
|
Professional, Scientific, and T...
|
| O: 3.25%
H: 4.04%
C: 2.25%
bmf-219 solid tumors presentation cel preclinical t-cell pre-clinical
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies- Completion of facility supports upcoming clinical milestones including expected multiple fourth quarter IND filings -
Published: 2021-12-02 (Crawled : 13:30) - biospace.com/
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $60.2 2.57% 0.0% 1.4M
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan milestone t-cell
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
Published: 2021-12-02 (Crawled : 12:30) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $60.2 2.57% 0.0% 1.4M
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan therapy t-cell
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit
Published: 2021-07-21 (Crawled : 12:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 0.0%
C: -9.54%
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 0.55%
H: 1.65%
C: 1.1%
covid disease media infectious disease therapy t-cell
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.